Regen BioPharma Inc (RGBP): Total Liabilities
$6.56M
As of 2025-09-30
$6.17M
As of 2026-06-30
-8.6%
3-year compound annual growth
-2.5%
5-year compound annual growth
+35.4%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $6.56M | +21.9% | 2025-12-30, Balance as of period end |
| 2024-09-30 | $5.38M | -1.5% | 2025-12-30, Balance as of period end |
| 2023-09-30 | $5.46M | -36.5% | 2025-05-13, Balance as of period end |
| 2022-09-30 | $8.60M | -41.5% | 2023-11-20, Balance as of period end |
| 2021-09-30 | $14.70M | +97.1% | 2022-11-15, Balance as of period end |
| 2020-09-30 | $7.46M | -32.2% | 2021-12-22, Balance as of period end |
| 2019-09-30 | $11.01M | +18.0% | 2021-08-04, Balance as of period end |
| 2018-09-30 | $9.33M | +50.6% | 2021-06-21, Balance as of period end |
| 2017-09-30 | $6.20M | +583.6% | 2018-12-27, Balance as of period end |
| 2016-09-30 | $906.3K | +185.3% | 2016-12-21, Balance as of period end |
| 2015-09-30 | $317.6K | +126.4% | 2016-12-21, Balance as of period end |
| 2014-09-30 | $140.3K | n/a | 2017-04-28, Balance as of period end |
| 2013-09-30 | $0 | n/a | 2014-12-18, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| Clene Inc. (CLNN) | 2025-12-31 | $35.72M | -1.3% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $7.76M | +13.9% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $2.74M | -52.6% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $3.14M | -44.7% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $7.00M | +0.4% |
| Medicinova Inc (MNOV) | 2025-12-31 | $4.02M | +19.1% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
Compare RGBP, CLNN, ABVC, HIND side by side · Screen every company in Pharmaceutical Preparations ↗